Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »Numbness Isn’t Always Diabetic Neuropathy: The Metformin-B12 Connection That’s Easy to Miss
Metformin B12 deficiency can cause numbness that resembles diabetic neuropathy. Learn who is at risk, when to test B12, and why early detection matters.
Read More »Pivot Just Got an FDA Update—Here’s What Actually Changed
The Pivot Insulin Delivery System received a new FDA clearance in September 2026. Learn what changed and what clinicians should know.
Read More »Type 2 Diabetes Damages the Pancreas, Or Does It?
New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »Same Blood Sugar, Different A1C? Your Red Blood Cells May Be Part of the Answer
Discover how red blood cell lifespan and biology can affect A1C results, explaining why similar glucose levels may produce different A1C readings.
Read More »Low Potassium, Higher Diabetes Risk? A Surprising Clue From Heart Failure Research
Low potassium is usually viewed through a cardiovascular lens, especially in patients with heart failure. However, emerging evidence suggests clinicians may have another reason to pay attention. New research examining the relationship between hypokalemia and diabetes risk found that lower serum potassium levels were associated with a greater risk of …
Read More »When “Normal” Blood Sugar Feels Too Low: New Research May Explain Why
When glucose numbers improve, patients are expected to feel better. Yet some people with type 1 diabetes report the opposite. A glucose level that looks reassuring on a continuous glucose monitor may leave them feeling tired, uncomfortable, or simply “off.” New research suggests that glycemic habituation may help explain this …
Read More »Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?
Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …
Read More »GLP-1s and Opioids: The GI Risk Clinicians May Be Missing
GLP-1 receptor agonists have transformed the treatment of type 2 diabetes, but their effects on gastrointestinal motility remain an important clinical consideration. Opioids can also slow gastrointestinal function, raising an obvious question: what happens when patients need both? New research examining GLP-1 and opioid interactions suggests that opioid choice may …
Read More »When “Type 2” Isn’t Type 2: Clues to Type 3c Diabetes
A patient develops diabetes in adulthood, so Type 2 diabetes may seem like the obvious diagnosis. However, what if that patient also has chronic pancreatitis, unexplained weight loss, pancreatic surgery, or symptoms of poor nutrient absorption? Those details can change the clinical picture. Careful evaluation can reveal Type 3c diabetes …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.